4//SEC Filing
Valamehr Bahram 4
Accession 0001209191-22-041670
CIK 0001434316other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:51 PM ET
Size
9.0 KB
Accession
0001209191-22-041670
Insider Transaction Report
Form 4
Valamehr Bahram
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2022-07-07$2.73/sh+17,158$46,841→ 196,992 total - Sale
Common Stock
2022-07-07$30.23/sh−17,158$518,686→ 179,834 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-07-07$2.73/sh−17,158$46,841→ 13,156 totalExercise: $2.73Exp: 2027-01-04→ Common Stock (17,158 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020.
- [F2]Represents the weighted average sale price of the shares sold ranging from $30.00 to $30.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range set forth in footnote 2.
- [F3]This option is fully vested.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001748177
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:51 PM ET
- Size
- 9.0 KB